Patents by Inventor Robert L. Wong

Robert L. Wong has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • COMFORTABLE OPHTHALMIC DEVICE AND METHODS OF ITS PRODUCTION
    Publication number: 20240142666
    Abstract: This invention relates to comfortable ophthalmic devices and methods of producing such devices.
    Type: Application
    Filed: October 18, 2023
    Publication date: May 2, 2024
    Inventors: Kevin P. McCabe, Robert B. Steffen, Hélène Aguilar, W. Anthony Martin, Susan W. Neadle, Ann-Marie Wong Meyers, Douglas G. Vanderlaan, Dominic P. Gourd, Kristy L. Canavan, Gregory A. Hill
  • Comfortable ophthalmic device and methods of its production
    Patent number: 11953651
    Abstract: This invention relates to comfortable ophthalmic devices and methods of producing such devices.
    Type: Grant
    Filed: August 24, 2021
    Date of Patent: April 9, 2024
    Assignee: Johnson & Johnson Vision Care, Inc.
    Inventors: Kevin P. McCabe, Robert B. Steffen, Hélène Aguilar, W. Anthony Martin, Susan W. Neadle, Ann-Marie Wong Meyers, Douglas G. Vanderlaan, Dominic P. Gourd, Kristy L. Canavan, Gregory A. Hill
  • USES AND COMPOSITIONS FOR TREATMENT OF ANKLOSING SPONDYLITIS
    Publication number: 20190040124
    Abstract: The invention provides methods, uses and compositions for the treatment of ankylosing spondylitis (AS). The invention describes methods and uses for treating ankylosing spondylitis, wherein a TNF? inhibitor, such as human TNF? antibody, or antigen-binding portion thereof, is used to reduce signs and symptoms of ankylosing spondylitis in a subject. Also described are methods for determining the efficacy of a TNF? inhibitor for treatment of ankylosing spondylitis in a subject.
    Type: Application
    Filed: February 28, 2018
    Publication date: February 7, 2019
    Inventors: Robert L. Wong, Hartmut Kupper, Michelle P. Luo, Joachim Sieper, John C. Davis, Desiree Van Der Heijde, Walter P. Maksymowych
  • USES AND COMPOSITIONS FOR TREATMENT OF PSORIATIC ARTHRITIS
    Publication number: 20170210795
    Abstract: The invention provides methods, uses and compositions for the treatment of psoriatic arthritis. The invention describes methods and uses for treating psoriatic arthritis, wherein a TNF? inhibitor, such as a human TNF? antibody, or antigen-binding portion thereof, is used to psoriatic arthritis in a subject. Also described are methods for determining the efficacy of a TNF? inhibitor for treatment of psoriatic arthritis in a subject.
    Type: Application
    Filed: April 13, 2017
    Publication date: July 27, 2017
    Inventors: John R. Medich, Robert L. Wong, Renee J. Perdok, Eric H. Sasso, Rebecca S. Hoffman, Philip Mease, Christopher T. Ritchlin
  • Uses and compositions for treatment of psoriatic arthritis
    Patent number: 9624295
    Abstract: The invention provides methods, uses and compositions for the treatment of psoriatic arthritis. The invention describes methods and uses for treating psoriatic arthritis, wherein a TNF? inhibitor, such as a human TNF? antibody, or antigen-binding portion thereof, is used to psoriatic arthritis in a subject. Also described are methods for determining the efficacy of a TNF? inhibitor for treatment of psoriatic arthritis in a subject.
    Type: Grant
    Filed: April 10, 2007
    Date of Patent: April 18, 2017
    Assignee: Abbvie Biotechnology Ltd.
    Inventors: John R. Medich, Robert L. Wong, Renee J. Perdok, Eric H. Sasso, Rebecca S. Hoffman, Phillip Mease, Christopher T. Ritchlin
  • Uses and Compositions for Treatment of Ankylosing Spondylitis
    Publication number: 20160251424
    Abstract: The invention provides methods, uses and compositions for the treatment of ankylosing spondylitis (AS). The invention describes methods and uses for treating ankylosing spondylitis, wherein a TNF? inhibitor, such as human TNF? antibody, or antigen-binding portion thereof, is used to reduce signs and symptoms of ankylosing spondylitis in a subject. Also described are methods for determining the efficacy of a TNF? inhibitor for treatment of ankylosing spondylitis in a subject.
    Type: Application
    Filed: March 7, 2016
    Publication date: September 1, 2016
    Inventors: Robert L. Wong, Hartmut Kupper, Michelle P. Luo, Joachim Sieper, John C. Davis, Desiree Van Der Heijde, Walter P. Maksymowych
  • Methods for treatment of ankylosing spondylitis using TNF alpha antibodies
    Patent number: 9279015
    Abstract: The invention provides methods, uses and compositions for the treatment of ankylosing spondylitis (AS). The invention describes methods and uses for treating ankylosing spondylitis, wherein a TNF? inhibitor, such as a human TNF? antibody, or antigen-binding portion thereof, is used to reduce signs and symptoms of ankylosing spondylitis in a subject. Also described are methods for determining the efficacy of a TNF? inhibitor for treatment of ankylosing spondylitis in a subject.
    Type: Grant
    Filed: February 4, 2008
    Date of Patent: March 8, 2016
    Inventors: Robert L. Wong, Hartmut Kupper, Michelle P. Luo, Joachim Sieper, John C. Davis, Walter P. Maksymowych
  • Methods and compositions for diagnosing ankylosing spondylitis using biomarkers
    Patent number: 9086418
    Abstract: The invention provides a method for determining the efficacy of a TNF? inhibitor, such as a TNF? antibody, or an antigen-binding portion thereof, for treating ankylosing spondylitis (AS), using a collagen degradation biomarker and/or a synovitis biomarker.
    Type: Grant
    Filed: February 25, 2011
    Date of Patent: July 21, 2015
    Assignee: ABBVIE BIOTECHNOLOGY LTD.
    Inventors: Walter P. Maksymowych, Robert L. Wong
  • Method of treating ankylosing spondylitis
    Patent number: 8926975
    Abstract: The invention provides methods, uses and compositions for the treatment of ankylosing spondylitis (AS). The invention describes methods and uses for treating ankylosing spondylitis, wherein a TNF? inhibitor, such as a human TNF? antibody, or antigen-binding portion thereof, is used to reduce signs and symptoms of ankylosing spondylitis in a subject. Also described are methods for determining the efficacy of a TNF? inhibitor for treatment of ankylosing spondylitis in a subject.
    Type: Grant
    Filed: June 17, 2014
    Date of Patent: January 6, 2015
    Assignee: AbbVie Biotechnology Ltd
    Inventors: Robert L. Wong, Hartmut Kupper, John R. Medich
  • METHOD OF TREATING ANKYLOSING SPONDYLITIS
    Publication number: 20140328855
    Abstract: The invention provides methods, uses and compositions for the treatment of ankylosing spondylitis (AS). The invention describes methods and uses for treating ankylosing spondylitis, wherein a TNF? inhibitor, such as a human TNF? antibody, or antigen-binding portion thereof, is used to reduce signs and symptoms of ankylosing spondylitis in a subject. Also described are methods for determining the efficacy of a TNF? inhibitor for treatment of ankylosing spondylitis in a subject.
    Type: Application
    Filed: June 17, 2014
    Publication date: November 6, 2014
    Inventor: Robert L. Wong
  • METHODS AND COMPOSITIONS FOR DIAGNOSING ANKYLOSING SPONDYLITIS USING BIOMARKERS
    Publication number: 20120129185
    Abstract: The invention provides a method for determining the efficacy of a TNF? inhibitor, such as a TNF? antibody, or an antigen-binding portion thereof, for treating ankylosing spondylitis (AS), using a collagen degradation biomarker and/or a synovitis biomarker.
    Type: Application
    Filed: February 25, 2011
    Publication date: May 24, 2012
    Applicant: ABBOTT BIOTECHNOLOGY LTD.
    Inventors: WALTER P. MAKSYMOWYCH, ROBERT L. WONG
  • Methods and compositions for determining the efficacy of a treatment for ankylosing spondylitis using biomarkers
    Patent number: 7919264
    Abstract: The invention provides a method for determining the efficacy of a TNF? inhibitor, such as a TNF? antibody, or an antigen-binding portion thereof, for treating ankylosing spondylitis (AS), using a collagen degradation biomarker and/or a synovitis biomarker.
    Type: Grant
    Filed: October 31, 2006
    Date of Patent: April 5, 2011
    Assignee: Abbott Biotechnology Ltd.
    Inventors: Walter P. Maksymowych, Robert L. Wong
  • Uses and compositions for treatment of ankylosing spondylitis
    Publication number: 20100021451
    Abstract: The invention provides methods, uses and compositions for the treatment of ankylosing spondylitis (AS). The invention describes methods and uses for treating ankylosing spondylitis, wherein a TNF? inhibitor, such as a human TNF? antibody, or antigen-binding portion thereof, is used to reduce signs and symptoms of ankylosing spondylitis in a subject. Also described are methods for determining the efficacy of a TNF? inhibitor for treatment of ankylosing spondylitis in a subject.
    Type: Application
    Filed: June 8, 2007
    Publication date: January 28, 2010
    Inventor: Robert L. Wong
  • Uses and compositions for treatment of ankylosing spondylitis
    Publication number: 20090123378
    Abstract: The invention provides methods, uses and compositions for the treatment of ankylosing spondylitis (AS). The invention describes methods and uses for treating ankylosing spondylitis, wherein a TNF? inhibitor, such as a human TNF? antibody, or antigen-binding portion thereof, is used to reduce signs and symptoms of ankylosing spondylitis in a subject. Also described are methods for determining the efficacy of a TNF? inhibitor for treatment of ankylosing spondylitis in a subject.
    Type: Application
    Filed: February 4, 2008
    Publication date: May 14, 2009
    Inventors: Robert L. Wong, Hartmut Kupper, Michelle P. Luo, Joachim Sieper, John C. Davis, Desiree Van Der Heijde, Walter P. Maksymowych
  • Uses and compositions for treatment of psoriatic arthritis
    Publication number: 20090028794
    Abstract: The invention provides methods, uses and compositions for the treatment of psoriatic arthritis. The invention describes methods and uses for treating psoriatic arthritis, wherein a TNF? inhibitor, such as a human TNF? antibody, or antigen-binding portion thereof, is used to psoriatic arthritis in a subject. Also described are methods for determining the efficacy of a TNF? inhibitor for treatment of psoriatic arthritis in a subject.
    Type: Application
    Filed: April 10, 2007
    Publication date: January 29, 2009
    Inventors: John R. Medich, Robert L. Wong, Renee J. Perdok, Eric H. Sasso, Rebecca S. Hoffman, Phillip Mease, Christopher T. Ritchlin
  • Spacecraft off-gimbal IRU precision payload pointing and disturbance rejection system
    Patent number: 6897821
    Abstract: An off-gimbal pointing system is improved using filtering of resolver and gyro responses respectively applied at the output of the resolvers and gyros for attenuating high frequencies resolver responses and gyro responses that effectively degrades the high frequency responses that are matched and above the control system bandwidth for improving the overall dynamic control of the off-gimbal pointing system for rejecting the affects of base motion disturbances and vibrations.
    Type: Grant
    Filed: August 4, 2003
    Date of Patent: May 24, 2005
    Assignee: The Aerospace Corporation
    Inventors: Robert L. Wong, Jason H. Q. Ly, Philip R. Dahl, Arthur C. Or